Andreas Halvorsen Viking Global Investors
Andreas Halvorsen is the founder of Viking Global Investors, another prominent firm with roots in Julian Robertson’s Tiger Management. Viking is known for fundamental long/short equity investing and a large, research-intensive platform. Its public filings are widely monitored for institutional-quality growth and cyclical equity ideas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$1.08B |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$786M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$538M |
| 4 |
Baidu
BIDU
|
+$456M |
| 5 |
LyondellBasell Industries
LYB
|
+$411M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$601M |
| 2 |
Danaher
DHR
|
+$476M |
| 3 |
Walt Disney
DIS
|
+$458M |
| 4 |
Bank of America
BAC
|
+$431M |
| 5 |
Cemex
CX
|
+$389M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 29.8% |
| 2 | Communication Services | 16.84% |
| 3 | Financials | 11.83% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Energy | 7.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
1
DELISTED
Walgreens Boots Alliance
WBA
| $1.59B | 6.68% |
24,105,841
+12,500,897
| +108% | +$786M |
|
|
TWX
2
DELISTED
Time Warner Inc
TWX
| $1.41B | 5.93% |
22,580,484
+8,577,506
| +61% | +$538M |
|
|
3
Illumina
ILMN
$33.1B
| $1.32B | 5.53% |
9,114,500
+7,370,023
| +422% | +$1.08B |
|
4
Bausch Health
BHC
$2.41B
| $1.23B | 5.14% |
9,296,143
+967,139
| +12% | +$132M |
|
|
TFCFA
5
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $1.21B | 5.09% |
37,933,856
+7,843,885
| +26% | +$256M |
|
6
Thermo Fisher Scientific
TMO
$233B
| $1.16B | 4.88% |
9,668,639
-707,017
| -7% | -$84.1M |
|
|
7
LyondellBasell Industries
LYB
$21.8B
| $1.14B | 4.8% |
12,859,004
+4,888,256
| +61% | +$411M |
|
8
Lowe's Companies
LOW
$121B
| $886M | 3.72% |
18,112,568
+328,832
| +2% | +$15.9M |
|
9
Capital One
COF
$134B
| $841M | 3.53% |
10,900,417
-1,735,335
| -14% | -$127M |
|
|
10
Baidu
BIDU
$31.6B
| $645M | 2.71% |
4,238,958
+2,727,117
| +180% | +$456M |
|
11
Valero Energy
VLO
$100B
| $644M | 2.7% |
12,131,872
-3,800,117
| -24% | -$195M |
|
12
Capri Holdings
CPRI
$1.55B
| $622M | 2.61% |
6,668,939
-1,673,666
| -20% | -$151M |
|
13
Canadian Pacific Kansas City
CP
$85B
| $605M | 2.54% |
20,115,235
-137,105
| -0.7% | -$4.16M |
|
14
Constellation Brands
STZ
$23.2B
| $596M | 2.5% |
7,014,138
+1,525,078
| +28% | +$121M |
|
15
Visa
V
$693B
| $593M | 2.49% |
10,982,604
+734,456
| +7% | +$40.8M |
|
16
Mastercard
MA
$509B
| $578M | 2.42% |
7,732,820
+1,311,950
| +20% | +$102M |
|
|
17
Meta Platforms (Facebook)
META
$1.4T
| $531M | 2.23% |
8,821,514
-9,479,888
| -52% | -$601M |
|
18
Mondelez International
MDLZ
$82.3B
| $529M | 2.22% |
15,312,675
+10,146,151
| +196% | +$347M |
|
19
H&R Block
HRB
$6.62B
| $515M | 2.16% |
17,053,916
-516,863
| -3% | -$15.5M |
|
20
Micron Technology
MU
$1.09T
| $489M | 2.05% |
20,667,617
-7,492,518
| -27% | -$178M |
|
|
CAM
21
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
| $482M | 2.02% |
7,811,219
+4,100,124
| +110% | +$249M |
|
|
MON
22
DELISTED
Monsanto Co
MON
| $352M | 1.48% |
3,097,531
-366,506
| -11% | -$40.8M |
|
23
Mohawk Industries
MHK
$9.23B
| $342M | 1.43% |
2,512,888
+1,861,838
| +286% | +$267M |
|
24
American International
AIG
$39.8B
| $316M | 1.33% |
6,323,360
+5,463,338
| +635% | +$272M |
|
25
Regeneron Pharmaceuticals
REGN
$85.9B
| $316M | 1.32% |
+1,051,800
| New | +$324M |
|
Similar funds
Andreas Halvorsen's Q1 2014 Portfolio in Review
As of Q1 2014, Andreas Halvorsen held 86 positions worth $23.8B, up 11% from $21.4B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Andreas Halvorsen deployed $1.65B of net new capital in Q1 2014, opening 21 new positions and adding to 22 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 1,051,800 shares worth $316M.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 26% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $601M trimmed.
- Andreas Halvorsen's largest Q1 2014 buy was Regeneron Pharmaceuticals: 1,051,800 shares worth $316M.
- Andreas Halvorsen added most to Illumina in Q1 2014, an estimated $1.08B increase.
- Andreas Halvorsen's biggest Q1 2014 reduction was Meta Platforms (Facebook), cutting an estimated $601M.
- Andreas Halvorsen fully exited Danaher in Q1 2014, selling an estimated $476M.
- Andreas Halvorsen's ten largest holdings make up 48% of its $23.8B portfolio in Q1 2014.
- Andreas Halvorsen opened 21 new positions and closed 26 in Q1 2014.
- Andreas Halvorsen's portfolio value rose 11% quarter-over-quarter to $23.8B.
Based on Viking Global Investors's 13F filing for Q1 2014, filed 15 May 2014.